BB Biotech AG (BBAGF)
OTC
76.06
0.00 (0.00%)
Real-time Data
01:30 PM
Day's Range
76.0676.06
52 wk Range
76.0676.06
Financial Statements - BBAGF - BB Biotech AG
Revenue
587.00M▲ 394.1%
Net Income
578.13M▲ 379.8%Net Margin 98.5%
Free Cash Flow
309.14M▲ 41.6%
Income Statement
| Period Ending | 2025-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | 2020-12-31 | 2019-12-31 |
|---|---|---|---|---|---|---|
| Sales | 587M | -199.56M | -351.22M | -396.22M | 699.23M | 685.23M |
| Cost of Goods | - | - | - | - | - | - |
| Gross Profit | - | - | - | - | - | - |
 Operating Expense | - | - | - | - | - | - |
| Operating Income | - | - | - | - | - | - |
| Non-Operating Interest | - | - | - | - | - | - |
| Other Income Expense | - | - | - | - | - | - |
| Pre Tax Income | 578.19M | -206.52M | -357.75M | -404.74M | 691.24M | 677.49M |
| Income Tax | 66K | 79K | 61K | 67K | 75K | 68K |
| Net Income | 578.13M | -206.60M | -357.81M | -404.80M | 691.17M | 677.43M |
| EPS Basic | - | - | - | -7.31 | 12.48 | 12.23 |
| EPS Diluted | - | - | - | -7.31 | 12.48 | 12.23 |
| Basic Shares Outstanding | - | - | - | 55.36M | 55.39M | 55.40M |
| Diluted Shares Outstanding | - | - | - | 55.36M | 55.39M | 55.40M |
| Ebit | - | - | - | - | - | - |
| Ebitda | - | - | - | - | - | - |
| Net Income Continuous Operations | - | - | - | - | - | - |
| Minority Interests | - | - | - | - | - | - |
| Preferred Stock Dividends | - | - | - | - | - | - |
The information on this page is provided for general informational purposes only and is not investment advice.
Market data provided by Twelve Data. Charting by TradingView.
Last updated:
